Oriental Rise Holdings Limited (NASDAQ: ORIS) announced on January 15 2026 that it had regained compliance with Nasdaq’s minimum bid‑price requirement under Listing Rule 5550(a)(2). The company’s closing bid price had been at or above $1.00 for the required ten consecutive business days from December 30 2025 through January 14 2026, satisfying Nasdaq’s compliance criteria.
The compliance issue stemmed from a 30‑day period of non‑compliance that began on May 15 2025 and ended on June 27 2025, when Nasdaq issued a deficiency notice. Oriental Rise’s 20:1 reverse stock split, completed on December 29 2025, lifted the share price above the $1.00 threshold and enabled the company to meet the ten‑day rule.
The announcement was welcomed by investors, as it removes the immediate risk of delisting and confirms the company’s continued eligibility to trade on the Nasdaq Capital Market. Management emphasized that regaining compliance reinforces its commitment to corporate governance and signals ongoing monitoring of Nasdaq listing standards.
While the company’s revenue trend has been downward in recent quarters, the successful compliance demonstrates operational resilience and the effectiveness of its capital structure strategy. The reverse split also reduced the number of shares outstanding, improving liquidity and aligning the company’s market presence with Nasdaq’s listing requirements.
Looking forward, Oriental Rise will continue to focus on maintaining bid‑price compliance while pursuing growth initiatives in its tea supply chain, including potential acquisitions and vertical integration. The company’s ability to navigate regulatory requirements positions it to capitalize on opportunities in the expanding Chinese tea market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.